About Us
Company Overview
MDClone is a technology firm focused on unlocking healthcare data and empowering exploration, discovery, and collaboration to improve patients' health.
At MDClone, we are a growing startup with big aspirations. We are determined to make an impact on healthcare worldwide with tools, processes, and services focused on turning data into better outcomes.
MDClone is focused on empowering healthcare institutions, enabling stronger and more secure relationships between healthcare providers and life science companies, and developing regional and global collaboration with privacy-enabled shared data sets.
The MDClone ADAMS Platform includes innovative synthetic data publishing capabilities that further enhance the protection of patient privacy.
Our unique technology enables any user of a healthcare organization to organize, access, and protect the privacy of patient data, empowering healthcare workers to rapidly transform ideas into actionable insights and take action.
Recently, MDClone was awarded Best Healthcare Big Data Platform by the MedTech Breakthrough Awards in both 2021 and 2022.
MDClone was also selected as a Technology Pioneer by the World Economic Forum in 2021 for the powerful MDClone ADAMS Platform.
Founded in 2016 in Israel and headquartered in Beer Sheba, MDClone has partnered with major health systems, government entities, payers, and life science companies around the world.
Current customers include Washington University School of Medicine in St. Louis, Intermountain Healthcare, the Regenstrief Institute, the VHA Innovation Ecosystem, The National Institutes of Health, The Ottawa Hospital, and Jewish-General Hospital in North America. In Israel, MDClone serves 100% of the Israeli healthcare market.
MDClone is backed by some of the most prominent investors in the U.S. and Israel: aMoon, Lightspeed, OrbiMed, Warburg Pincus, and Viola Growth.
See Jobs (2)
MDClone is a technology firm focused on unlocking healthcare data and empowering exploration, discovery, and collaboration to improve patients' health.
At MDClone, we are a growing startup with big aspirations. We are determined to make an impact on healthcare worldwide with tools, processes, and services focused on turning data into better outcomes.
MDClone is focused on empowering healthcare institutions, enabling stronger and more secure relationships between healthcare providers and life science companies, and developing regional and global collaboration with privacy-enabled shared data sets.
The MDClone ADAMS Platform includes innovative synthetic data publishing capabilities that further enhance the protection of patient privacy.
Our unique technology enables any user of a healthcare organization to organize, access, and protect the privacy of patient data, empowering healthcare workers to rapidly transform ideas into actionable insights and take action.
Recently, MDClone was awarded Best Healthcare Big Data Platform by the MedTech Breakthrough Awards in both 2021 and 2022.
MDClone was also selected as a Technology Pioneer by the World Economic Forum in 2021 for the powerful MDClone ADAMS Platform.
Founded in 2016 in Israel and headquartered in Beer Sheba, MDClone has partnered with major health systems, government entities, payers, and life science companies around the world.
Current customers include Washington University School of Medicine in St. Louis, Intermountain Healthcare, the Regenstrief Institute, the VHA Innovation Ecosystem, The National Institutes of Health, The Ottawa Hospital, and Jewish-General Hospital in North America. In Israel, MDClone serves 100% of the Israeli healthcare market.
MDClone is backed by some of the most prominent investors in the U.S. and Israel: aMoon, Lightspeed, OrbiMed, Warburg Pincus, and Viola Growth.